Conference Summaries: Day Two<BR> Monday, September 18, 2000

The Body Covers: The 40th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy

Conference Summaries: Day Two
Monday, September 18, 2000

Clinical Trials of Antiretroviral Therapy
Adherence to Antiretroviral Therapy
- Patient Adherence with Twice Daily Dosing of Nelfinavir (NLF) Equivalent to Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) when Given in Combination with Dual Nucleoside Analogues (NRTI) (Poster 791)
  Coverage by Alvan E. Fisher, M.D.
Primary HIV Infection
Symposium: Viral Co-Infection with HIV
- Hepatitis C (Presentation 1141)
  Coverage by Alvan E. Fisher, M.D.
- CMV (Presentation 1142)
  Coverage by Alvan E. Fisher, M.D.
- HHV-8 and HIV (Presentation 1143)
  Coverage by Alvan E. Fisher, M.D.
- HPV (Presentation 1144)
  Coverage by Alvan E. Fisher, M.D.
New Approaches with Antiretroviral Therapy
Analysis of Genotypes Prior to Antiretroviral Therapy
- Low Prevalence of Key Resistance Mutations in Geographically Diverse, Therapy Naive, HIV-1 Infected Subjects in North America (Poster 1248)
  Coverage by Mark Holodniy, M.D.
Antiretroviral Resistance and Resistance Testing
Lipodystrophy and Metabolic Disorders in HIV Therapeutics

Next Day's Sessions

Return to The Body's coverage of
The 40th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy.

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.